Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f46ae8a522d204f38a338161d0294316 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d5bb9b9a6d998b72b154ceb1895a3f5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
filingDate |
2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_977093be66c03af5d2e195319ba3be21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8ee18a86b74e94f43fa955ce4e1fd19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_651f9ec340f7f2b67fd7fce132bc306f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57c8cc459fa816d61643834fc5d622f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc71e42e8be36c09bbe6964d4c686909 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c859f49257436bdcb9725c1ab449131 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7351462438a1693bebca9fb494e5d98 |
publicationDate |
2012-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1706403-B1 |
titleOfInvention |
Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
abstract |
The present invention relates to pharmaceutical compositions for the treatment or prevention of viral infections comprising as an active principle at least one imidazo[4,5-c]pyridine prodrug having the general Formula (A) wherein the substituents are described in the specification. The invention also relates to processes for the preparation and screening of compounds according to the invention having above mentioned general Formula and their use in the treatment or prophylaxis of viral infections. |
priorityDate |
2003-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |